PANORAMA
Luohe Nanjiecun Pharmaceutical Group Pharmacy Co., Ltd. is a professional company engaged in the production of Rifamycin series Active Pharmaceutical Ingredient, located in Luohe City, Henan Province. Luohe Nanjiecun Pharmaceutical Group Pharmacy Co., Ltd. enjoys a good environment and transport facilities. Having pleasant weather, this is one of the ideal place for pharmaceutical production.
The predecessor of the company, Luohe Jixiong Pharmacy Co., Ltd. was established in 1988, covers an area of 55000 square meters, is the nation’s largest Rifamycin series API production facility, high-tech enterprises in Henan Province.
In 2004, it was authorized GMP by the State Food & Drug Administration Bureau.
DMF for Rifampicin was completed in 2005 and the product is Registered in India since 2006.
In 2011, our plant was audited by Drug Control Center by Government of India (DCGI).
Rifampicin was also registered in Russia in 2008.
Leading Products
Annual Output
Rifampicin
400 t
Rifaximin
100 t
Rifamycin SV Sodium
600 t
Rifamycin S
300 t
PRODUCT
QUALITY
Our key API Rifampicin complies with various pharmacopeial standards like CP, BP, EP, IP, USP.
All of our products are sold well in domestic as well as various export markets. We export to Southeast Asia, India, Russia, Pakistan, Germany, North America, South America, Africa, etc.
We have also developed some new products like Rifamycin Sodium, Rifaximin, Rifabutin and Rifapentine which have great potential in global markets.
NEWS
Rifabutin is an antibiotic that fights bacteria. Generic Name: rifabutin (RIF a BUE
China Pharma Forecast 2019-2023
China has expanded to be the second largest pharmaceutical market globally with USD 137 billion in total spending in 2018, but growth has slowed from a 19% CAGR in 2008–2013 to an 8% CAGR in 2013–2018
What is multidrug-resistant tuberculosis and how do we control it?
The bacteria that cause tuberculosis (TB) can develop resistance to the antimicrobial drugs used to cure the disease. Multidrug-resistant TB (MDR-TB) is TB that does not respond to at least isoniazid and rifampicin, the 2 most
Rifaximin, an antibiotic used to treat Travelers Diarrhea, Irritable Bowel Syndrome, and Hepatic Encephalopathy. Traveller Diarrhea Traveler diarrhea is a gastrointestinal infection. Rifaximin, as an antibiotic and not easily absorbed by the intestine, is widely used
